rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-6-28
|
pubmed:abstractText |
Intact parathyroid hormone (PTH) assay has recently been reported to be effective in evaluating both 1-84 PTH (whole PTH) and inactive 7-84 PTH. Inactive 7-84 PTH is considered to be increased in hemodialysis patients and to prevent the effects of 1-84 PTH, and intact PTH is considered to overestimate the PTH activity in these patients. As such, a whole PTH assay has recently been developed. The purpose of this study was to examine the usefulness of a whole PTH assay using the bone to soft tissue (B/ST) ratio on bone scintigraphy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0914-7187
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
179-84
|
pubmed:meshHeading |
pubmed-meshheading:15981669-Adult,
pubmed-meshheading:15981669-Aged,
pubmed-meshheading:15981669-Bone and Bones,
pubmed-meshheading:15981669-Female,
pubmed-meshheading:15981669-Humans,
pubmed-meshheading:15981669-Male,
pubmed-meshheading:15981669-Middle Aged,
pubmed-meshheading:15981669-Parathyroid Hormone,
pubmed-meshheading:15981669-Prognosis,
pubmed-meshheading:15981669-Radiopharmaceuticals,
pubmed-meshheading:15981669-Renal Osteodystrophy,
pubmed-meshheading:15981669-Reproducibility of Results,
pubmed-meshheading:15981669-Sensitivity and Specificity,
pubmed-meshheading:15981669-Technetium Tc 99m Medronate
|
pubmed:year |
2005
|
pubmed:articleTitle |
Usefulness of whole PTH assay in patients with renal osteodystrophy--correlation with bone scintigraphy.
|
pubmed:affiliation |
Division of Nuclear Medicine, PET Center and Department of Radiology, Kurume University School of Medicine, Fukuoka, Japan. hayato@med.kurume-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Validation Studies
|